Iron Chelation Therapy in Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) are a heterogeneous disorder of the hematopoietic stem cells, frequently characterized by anemia and transfusion dependency. In low-risk patients, transfusion dependency can be long lasting, leading to iron overload. Iron chelation therapy may be a therapeutic option...

Descripción completa

Detalles Bibliográficos
Autores principales: Messa, Emanuela, Cilloni, Daniela, Saglio, Giuseppe
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905902/
https://www.ncbi.nlm.nih.gov/pubmed/20672005
http://dx.doi.org/10.1155/2010/756289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905902/
https://www.ncbi.nlm.nih.gov/pubmed/20672005
http://dx.doi.org/10.1155/2010/756289

Ejemplares similares